Robert N Baldassano
Overview
Explore the profile of Robert N Baldassano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
12638
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang D, Stein R, Lu Y, Zhou T, Lei Y, Li L, et al.
JAMA Netw Open
. 2025 Feb;
8(2):e2458366.
PMID: 39918822
Importance: The profile of gastrointestinal (GI) tract outcomes associated with the postacute and chronic phases of COVID-19 in children and adolescents remains unclear. Objective: To investigate the risks of GI...
2.
Mitchel E, Dolinger M, Constant B, Wang Z, Guisado D, Gao M, et al.
J Pediatr Gastroenterol Nutr
. 2025 Jan;
PMID: 39888083
Objectives: Real-world data on ustekinumab for the treatment of pediatric Crohn's disease (CD) are limited. This study sought to evaluate the effectiveness, long-term durability, and safety of ustekinumab in the...
3.
Breton J, Tu V, Tanes C, Wilson N, Quinn R, Kachelries K, et al.
J Crohns Colitis
. 2025 Jan;
19(2).
PMID: 39887086
Background And Aims: Epidemiological studies have suggested an association between the inflammatory potential of dietary patterns and Crohn's disease (CD). However, the relationships of these inflammatory dietary determinants with the...
4.
Lisai-Goldstein Y, Focht G, Orlanski-Meyer E, Yogev D, Lev-Tzion R, Ledder O, et al.
Dig Dis Sci
. 2024 Nov;
70(1):333-339.
PMID: 39604667
Background: To advance personalized medicine in pediatric Crohn's disease (CD), we aimed to explore the utility of serological biomarkers in predicting response to anti-tumor necrosis factor (TNF). Methods: Children with...
5.
Zhang D, Stein R, Lu Y, Zhou T, Lei Y, Li L, et al.
medRxiv
. 2024 Jun;
PMID: 38826331
Importance: The profile of gastrointestinal (GI) outcomes that may affect children in post-acute and chronic phases of COVID-19 remains unclear. Objective: To investigate the risks of GI symptoms and disorders...
6.
Conrad M, Bittinger K, Ren Y, Kachelries K, Vales J, Li H, et al.
Gut Microbes
. 2024 Feb;
16(1):2317932.
PMID: 38404111
Dysbiosis is associated with pediatric and adult-onset inflammatory bowel disease (IBD), but the role of dysbiosis and the microbiome in very early onset IBD (VEO-IBD) has not yet been described....
7.
Zhang D, Tong J, Stein R, Lu Y, Jing N, Yang Y, et al.
J Biomed Inform
. 2024 Jan;
150:104595.
PMID: 38244958
Objective: To characterize the interplay between multiple medical conditions across sites and account for the heterogeneity in patient population characteristics across sites within a distributed research network, we develop a...
8.
Geem D, Hercules D, Pelia R, Venkateswaran S, Griffiths A, Noe J, et al.
Clin Gastroenterol Hepatol
. 2023 Oct;
22(2):368-376.e4.
PMID: 37802268
Background & Aims: The evolution of complicated pediatric Crohn's disease (CD) in the era of anti-tumor necrosis factor (aTNF) therapy continues to be described. Because CD progresses from inflammatory to...
9.
Crisci M, Vellanki S, Baldassano R, Chen Y, Liu Y, Stein R, et al.
J Pediatr Endocrinol Metab
. 2023 Oct;
36(11):1012-1017.
PMID: 37795854
Objectives: Impaired linear growth is a known complication of pediatric inflammatory bowel disease (IBD), but the use of growth hormone (GH) in this population is not well-described. The primary aim...
10.
Lemons J, Conrad M, Tanes C, Chen J, Friedman E, Roggiani M, et al.
Cell Mol Gastroenterol Hepatol
. 2023 Sep;
17(1):131-148.
PMID: 37739064
Background & Aims: Altered plasma acylcarnitine levels are well-known biomarkers for a variety of mitochondrial fatty acid oxidation disorders and can be used as an alternative energy source for the...